Cargando…
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer
Current liquid biopsy assays lack sufficient sensitivity to detect copy number loss, which limits the interrogation of critical tumor suppressor gene deletions during cancer progression and treatment. Here we describe a liquid biopsy assay with improved sensitivity for detection of copy number loss...
Autores principales: | Dong, Xiaoxi, Zheng, Tiantian, Zhang, Minhua, Dai, Chao, Wang, Lili, Wang, Lei, Zhang, Ruipeng, Long, Yuan, Wen, Danyi, Xie, Feng, Zhang, Yue, Huang, Yong, Dong, Jianguo, Liu, Huan, Du, Pan, King, Bonnie L., Tan, Winston, Jia, Shidong, Lu, Chris X., Kohli, Manish, Wang, Haitao, Yu, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422845/ https://www.ncbi.nlm.nih.gov/pubmed/34504797 http://dx.doi.org/10.3389/fonc.2021.720727 |
Ejemplares similares
-
Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer
por: Tan, Winston, et al.
Publicado: (2022) -
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022) -
Pitfalls in Experimental Designs for Characterizing the Transcriptional, Methylational and Copy Number Changes of Oncogenes and Tumor Suppressor Genes
por: Zhang, Yuannv, et al.
Publicado: (2013) -
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer
por: Huang, Jinyong, et al.
Publicado: (2022) -
Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer
por: Xia, Yun, et al.
Publicado: (2016)